Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.442
-0.058 (-3.87%)
Aug 14, 2025, 1:12 PM - Market open
Sunshine Biopharma Market Cap
Sunshine Biopharma has a market cap or net worth of $6.57 million as of August 14, 2025. Its market cap has decreased by -4.65% in one year.
Market Cap
6.57M
Enterprise Value
-2.54M
1-Year Change
-4.65%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since October 30, 2009, Sunshine Biopharma's market cap has decreased from $160.32M to $6.57M, a decrease of -95.90%. That is a compound annual growth rate of -18.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 6.83M | 13.92% |
| Dec 31, 2024 | 6.00M | -13.95% |
| Dec 29, 2023 | 6.97M | -51.77% |
| Dec 30, 2022 | 14.45M | -52.26% |
| Dec 31, 2021 | 30.28M | 480.17% |
| Dec 31, 2020 | 5.22M | 1,941.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |